» Articles » PMID: 37947638

Mass Spectrometry-Based Proteomic Technology and Its Application to Study Skeletal Muscle Cell Biology

Overview
Journal Cells
Publisher MDPI
Date 2023 Nov 10
PMID 37947638
Authors
Affiliations
Soon will be listed here.
Abstract

Voluntary striated muscles are characterized by a highly complex and dynamic proteome that efficiently adapts to changed physiological demands or alters considerably during pathophysiological dysfunction. The skeletal muscle proteome has been extensively studied in relation to myogenesis, fiber type specification, muscle transitions, the effects of physical exercise, disuse atrophy, neuromuscular disorders, muscle co-morbidities and sarcopenia of old age. Since muscle tissue accounts for approximately 40% of body mass in humans, alterations in the skeletal muscle proteome have considerable influence on whole-body physiology. This review outlines the main bioanalytical avenues taken in the proteomic characterization of skeletal muscle tissues, including top-down proteomics focusing on the characterization of intact proteoforms and their post-translational modifications, bottom-up proteomics, which is a peptide-centric method concerned with the large-scale detection of proteins in complex mixtures, and subproteomics that examines the protein composition of distinct subcellular fractions. Mass spectrometric studies over the last two decades have decisively improved our general cell biological understanding of protein diversity and the heterogeneous composition of individual myofibers in skeletal muscles. This detailed proteomic knowledge can now be integrated with findings from other omics-type methodologies to establish a systems biological view of skeletal muscle function.

Citing Articles

Proteomic reference map for sarcopenia research: mass spectrometric identification of key muscle proteins located in the sarcomere, cytoskeleton and the extracellular matrix.

Dowling P, Gargan S, Zweyer M, Henry M, Meleady P, Swandulla D Eur J Transl Myol. 2024; 34(2).

PMID: 38787300 PMC: 11264229. DOI: 10.4081/ejtm.2024.12564.


Proteomic reference map for sarcopenia research: mass spectrometric identification of key muscle proteins of organelles, cellular signaling, bioenergetic metabolism and molecular chaperoning.

Dowling P, Gargan S, Zweyer M, Henry M, Meleady P, Swandulla D Eur J Transl Myol. 2024; 34(2).

PMID: 38787292 PMC: 11264233. DOI: 10.4081/ejtm.2024.12565.


How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?.

Dowling P, Trollet C, Negroni E, Swandulla D, Ohlendieck K Proteomes. 2024; 12(1).

PMID: 38250815 PMC: 10801633. DOI: 10.3390/proteomes12010004.

References
1.
Xu X, Jiang X, Shi M, Yin L . Mass spectrometry-based techniques for single-cell analysis. Analyst. 2023; 148(16):3690-3707. DOI: 10.1039/d3an00370a. View

2.
Sunderhaus S, Eubel H, Braun H . Two-dimensional blue native/blue native polyacrylamide gel electrophoresis for the characterization of mitochondrial protein complexes and supercomplexes. Methods Mol Biol. 2008; 372:315-24. DOI: 10.1007/978-1-59745-365-3_23. View

3.
Schiaffino S, Reggiani C, Kostrominova T, Mann M, Murgia M . Mitochondrial specialization revealed by single muscle fiber proteomics: focus on the Krebs cycle. Scand J Med Sci Sports. 2015; 25 Suppl 4:41-8. DOI: 10.1111/sms.12606. View

4.
Ab Malik Z, Cobley J, Morton J, Close G, Edwards B, Koch L . Label-Free LC-MS Profiling of Skeletal Muscle Reveals Heart-Type Fatty Acid Binding Protein as a Candidate Biomarker of Aerobic Capacity. Proteomes. 2014; 1(3):290-308. PMC: 3997170. DOI: 10.3390/proteomes1030290. View

5.
Anunciado-Koza R, Guntur A, Vary C, Gartner C, Nowak M, Koza R . Purification of functional mouse skeletal muscle mitochondria using percoll density gradient centrifugation. BMC Res Notes. 2023; 16(1):243. PMC: 10544150. DOI: 10.1186/s13104-023-06519-4. View